NEW YORK, Sept. 4 - French pharmaceutical company Sanofi-Synthelabo has become the latest subscriber to LifeSpan BioSciences' G protein-coupled receptor expression and location database, LifeSpan announced on Tuesday.

Sanofi will use LifeSpan’s database of GPCR expression and location information in normal and diseased tissues to help it identify and validate new drug targets.

Financial details of the agreement were not disclosed. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.